ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2025
Uses of the ICECAP measure of capability in adults with neurological health conditions: a scoping review.
Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose was to identify how the ICECAP-A and ICECAP-O have been used with adults who have neurological health conditions.
methodsFollowing the Joanna Briggs Institute framework, a scoping review was conducted, searching five databases (Scopus, CINAHL, MEDLINE, Embase, and PsycINFO). Studies were included if participants were adults (age 18+ years) with neurological health conditions, and ICECAP-A or ICECAP-O were used in the study. Exclusions included studies about mental health conditions, protocols, and abstracts. Two authors screened abstracts and full texts independently. Conflicts were resolved through consensus. Data were categorized and synthesized.
resultsSearch results included 1163 articles and 571 studies were screened. The team reviewed 37 full-text articles, with 14 studies included. Eleven studies utilized ICECAP-O; three utilized ICECAP-A. Nine studies were from Europe, three from Canada, and two from Australia. The uses of ICECAP measures included psychometric studies (9), economic evaluation (3), program evaluation (1), and testing associations (1). Nine studies focused on dementia, with 7 of those including proxy evaluations, two studies involved individuals with spinal cord injury, and one study each focused on individuals with Parkinson's disease, epilepsy, and various neurological conditions. Both ICECAP-O and ICECAP-A were referred to in the studies as measures of well-being, capability, quality of life or some combination.
conclusionsICECAP-O has not been thoroughly examined in neurological health conditions outside of dementia. There is potential for further psychometric testing of both ICECAP-A and ICECAP-O in neurological conditions and research into the application of capability measures in clinical and research settings.
Indexed as
Identifiers
40914758What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.